Flexion Therapeutics Granted Fast Track Status by the FDA for FX006 for Treatment of Osteoarthritis of the Knee

Go back to Flexion Therapeutics Granted Fast Track Status by the FDA for FX006 for Treatment of Osteoarthritis of the Knee
FLEXION THERAPEUT (NYSE: FLXN) Delayed: 25.05 +0.01 (0.04%)
Previous Close $25.04    52 Week High $23.57 
Open $25.05    52 Week Low $7.56 
Day High $25.08    P/E N/A 
Day Low $25.02    EPS $-2.04 
Volume 4,268